Your Cart is Empty!
You must add items to your cart before you can proceed to checkout.
Dimethylmethoxy Chromanyl Palmitate (Chromabright)
Targets uneven pigmentation with high efficacy and zero irritation, making it ideal for long-term melasma management.
Chromabright® acts as a selective tyrosinase inhibitor, directly disrupting the enzyme responsible for melanin synthesis—the root cause of melasma spots. Unlike harsh lighteners, it’s non-irritating and photostable, so it can be used safely in daytime formulations without increasing photosensitivity. It also protects skin from UV-induced oxidative stress, a major melasma trigger, helping prevent recurrence. Ideal for targeted treatments on stubborn melasma-prone areas and for use in combination therapies.
Dimethylmethoxy Chromanyl Palmitate (Chromabright)
Targets uneven pigmentation with high efficacy and zero irritation, making it ideal for long-term melasma management.
Chromabright® acts as a selective tyrosinase inhibitor, directly disrupting the enzyme responsible for melanin synthesis—the root cause of melasma spots. Unlike harsh lighteners, it’s non-irritating and photostable, so it can be used safely in daytime formulations without increasing photosensitivity. It also protects skin from UV-induced oxidative stress, a major melasma trigger, helping prevent recurrence. Ideal for targeted treatments on stubborn melasma-prone areas and for use in combination therapies.
Effectively fades dark melasma patches and uneven pigmentation.
Inhibits tyrosinase to reduce melanin synthesis at the source.
Gentle on sensitive and reactive skin prone to melasma.
Photostable—safe for daytime use alongside sunscreens.
Protects against UV damage and oxidative stress that worsen melasma.
